See also this year's filing and all EDGAR filings for this company.
PDF Report 0001485003_2023_Carisma_Therapeutics_Inc.pdf
Logs
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001485003, Carisma Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 189,144,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 30,000 |
| 4 | LiabilitiesCurrent | 30,984,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 39,787,000 |
| 9 | ResearchAndDevelopmentExpense | 38,594,000 |
| 10 | remainder_Expenses | -16,347,000 |
| 11 | remainder_Revenues | 40,000,000 |
| 12 | remainder_NetIncome | 2,150,000 |
| 13 | remainder_ComprehensiveNetIncome | -546,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 189,174,000 |
| 1 | Liabilities | 30,984,000 |
| 2 | Expenses | 62,034,000 |
| 3 | Revenues | 40,000,000 |
| 4 | StockholdersEquity | 158,190,000 |
| 5 | NetIncome | -19,884,000 |
| 6 | ComprehensiveNetIncome | -20,157,000 |
| 7 | BaseVar | 162,444,000 |
| 8 | EconomicCapitalRatio | 2.29 |
Edgar->Model Mapping
Feature Distribution
Change over Time
